期刊文献+

ABCG2在人脑胶质瘤中的表达及其与Cyclin D_2的关系 被引量:1

Expression of ABCG2 and Its Relationship with Cyclin D_2 in Human Brain Gliomas
下载PDF
导出
摘要 目的探讨ABCG2在人脑胶质瘤组织中的表达及其与胶质瘤分级和Cyclin D2表达的关系。方法实时荧光定量PCR法检测ABCG2在52例不同病理级别胶质瘤及8例正常脑组织中的mRNA表达;免疫组织化学SABC法检测ABCG2和Cyclin D2的蛋白表达;SPSS统计分析其表达的相关性。结果ABCG2在脑胶质瘤中的mRNA表达与正常脑组织相比存在过表达(P<0.05),且随着病理级别的升高而增加(P<0.05);免疫组化检测显示ABCG2在52例胶质瘤中的阳性表达率为32.7%(17/52),与病理级别具有明显相关性(χ2=4.62,P<0.05),呈亲血管分布;ABCG2的表达与Cyclin D2的表达具有一定的相关性(P<0.05)。结论ABCG2在人脑胶质瘤中的表达随着病理级别的升高而逐渐增加,且与Cyclin D2的表达呈正相关,表明以ABCG2为标志物的脑肿瘤干细胞具有较高的增殖能力。 Objective To investigate the expression and significance of ABCG2 and its relationship with WHO pathological grade and Cyclin D2 in human gliomas.Methods Fifty-two cases of gliomas with different WHO grades and 8 cases of normal brain tissues were detected for the mRNA expression of ABCG2 by using real-time quantitative PCR.The protein expression of ABCG2 and Cyclin D2 was assayed by immunohistochemistry.The correlation was analyzed by SPSS 12.0 software.Results The mRNA of ABCG2 was overexpressed in gliomas as compared with that in normal brain tissues,and up-regulated with the increase of pathologic degree(P0.05).The positive protein expression rate of ABCG2 in 52 cases of gliomas was 32.7%.The positive rate was significantly higher in grade Ⅲ-Ⅳ than that in grade Ⅰ-Ⅱ(χ2 =4.62,P0.05).The expression level of Cyclin D2 was obviously related with the expression of ABCG2(P0.05).Conclusion The expression level of ABCG2 was obviously related with glioma pathological grade and the expression of Cyclin D2.Brain tumor stem cells characterized by positive expression of ABCG2 may show heavy potency of malignant proliferation.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2010年第2期236-238,242,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省自然科学基金资助项目(No.2008CDB191)
关键词 ABCG2 胶质瘤 脑肿瘤干细胞 细胞周期素D2 ABCG2 glioma brain tumor stem cells Cyclin D2
  • 相关文献

参考文献13

  • 1Iguatova T N,Kukekov V G,Laywell E D,et al.Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro[J].Glia,2002,39(3):193-206.
  • 2Vescovi A L,Galli R,Reynolds B A.Brain tumour stem cells[J].Nat Rev Cancer,2006,6(6):425-433.
  • 3Zhang W,Mojsilovic-Petrovic J,Andrade M F,et al.The expression and functional characterization of ABCG2 in brain endothelial cells and vessels[J].FASEB J,2003,17(14):2085-2087.
  • 4Mohan A,Kandalam M,Ramkumar H L,et al.Stem cell mar-kers:ABCG2 and MCM2 expression in retinoblastoma[J].Br J Ophthalmol,2006,90(7):889-893.
  • 5Bailey-Dell K J,Hassel B,Doyle L A,et al.Promoter characterization and genomic organization of the human breast cancer resistance protein(ATP-binding cassette transporter G2)gene[J].Biochim Biophys Acta,2001,1520(3):234-241.
  • 6Zhou S,Schuetz J D,Bunting K D,et al.The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[J].Nat Med,2001,7(9):1028-1034.
  • 7Scharenberg C W,Harkey M A,Torok-Storb B,et al.The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors[J].Blood,2002,99(2):507-512.
  • 8Kondo T,Setoguchi T,Taga T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line[J].PNAS,2004,101(3):781-786.
  • 9Cistemino S,Mercier C,Bourasset F,et al.Expression,up-regulation,and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier[J].Cancer Res,2004,64(9):3296-3301.
  • 10Yao J,Zhang Q B,Huang Q,et al.ABCG2 is related with the grade of glioma and resistance to mitoxantone,a chemotherapeutic drug for glioma[J].J Cancer Res Clin Oncol,2009,135(10):1369-1376.

二级参考文献11

  • 1Sherr CJ.Cancer cell cycles[J].Science,1996,274(5293):1672-1677.
  • 2Ito Y,Yoshida H,Nakano K,et al.Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues[J].Int J Mol Med,2002,9 (4):373-376.
  • 3Ito Y,Takeda T,Sasaki Y,et al.Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma[J].Liver,2002,22(2):145-149.
  • 4Lee MH,Reynisdottir I,Massague J.Cloning of p57^kip2,a cyclindependent kinase inhibitor with unique domain instructure and tissued distribution[J].Genes Dev,1995,9 (6):639 -649.
  • 5Lai S,Goepfert H,Gillenwater AM,et al.Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2gene in head and neck squamous cell carcinoma[J].Clin Cancer Res,2000,6(8):3172 -3176.
  • 6Matsuoka S,Edwards MS,Bai C,et al.p57kip2,a structurally distinct member of the p21cip1 Cdk inhibitor family,is a candicate tumor suppressor gene[J].Genes Dev,1995,9 (6):650 -662.
  • 7Nakai S,Masaki T,Shiratori Y,et al.Expression of p57(kip2) in hepatocellular carcinoma:relationship between tumor differentiation and patient surrival[J].Int J Oncol,2002,20(4):769 -775.
  • 8Milde-Langosch K,Hagen M,Bamberger AM,et al.Expression and prognostic value of the cell-cycle regulatory proteins,Rb,p16MTS1,p21WAF1,p27KIP1,cyclin E,and cyclin D2,in ovarian Cancer[J].Int J Gynecol Pathol,2003,22(2):168-174.
  • 9Takano Y,Kato Y,Masuda M,et al.Cyclin D2,but not Cyclin D1,overexpression closely correlates with gastric cancer progression and prognosis[J].J Pathol,1999,189 (2):194 -200.
  • 10Liu SC,Bassi DE,Zhang SY,et al.Overexpression of cyclin D2 is associated with increased in vivo invssiveness of human squamous carcinoma cells[J].Mol Carcinog,2002,34 (3):131-139.

共引文献2

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部